Akero Therapeutics Inc. (AKRO)

42.66

-0.92 (-2.11%)

At close: Mar 28, 2025, 3:59 PM

42.53

-0.30%

After-hours: Mar 28, 2025, 07:55 PM EDT

Akero Therapeutics Cash Flow Statement

Table Mode

Year	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Net Income	-252.06M	-151.76M	-112.03M	-100.78M	-79.21M	-43.76M	-81.71M	-4.56M
Depreciation & Amortization	-13.1M	29K	43K	41K	17K	-104K	n/a	n/a
Stock-Based Compensation	29.7M	21.5M	23.24M	10.05M	6.02M	1.77M	121K	n/a
Other Working Capital	990K	-6.03M	-5.43M	6.45M	-396K	6.89M	-252K	122K
Other Non-Cash Items	2.36M	-8.46M	689K	203K	196K	-104K	75.91M	-60K
Deferred Income Tax	n/a	n/a	n/a	1.07M	83K	104K	n/a	n/a
Change in Working Capital	3M	-6.67M	-4.46M	9.73M	2.08M	6.46M	1.06M	182K
Operating Cash Flow	-230.11M	-145.37M	-92.52M	-79.68M	-70.8M	-35.63M	-4.63M	-4.38M
Capital Expenditures	n/a	n/a	n/a	n/a	-148K	n/a	-5M	n/a
Acquisitions	n/a	n/a	n/a	n/a	9.61K	n/a	n/a	n/a
Purchase of Investments	-516.04M	-433.12M	-101.45M	-43.56M	-115.04M	-71.51M	n/a	n/a
Sales Maturities Of Investments	407.33M	209.5M	37.62M	85.84M	105.42M	n/a	n/a	n/a
Other Investing Acitivies	-999K	n/a	-63.83K	42.28K	-9.61K	-71.51K	-5K	n/a
Investing Cash Flow	-109.71M	-223.62M	-63.83M	42.28M	-9.76M	-71.51M	-5M	n/a
Debt Repayment	10M	15M	10M	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	464K	n/a	n/a	373K	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	12.77M	2.89M	4.43M	602K	553K	536K	85.01M	5M
Financial Cash Flow	445.85M	353.32M	255.63M	602K	203.11M	95.99M	85.01M	5M
Net Cash Flow	106.03M	-15.67M	99.29M	-36.8M	122.54M	-11.15M	75.38M	618K
Free Cash Flow	-230.11M	-145.37M	-92.52M	-79.68M	-70.95M	-35.63M	-9.63M	-4.38M